Recently the DEA reclassified hydrocodone from a CIII to a CII. In determining which schedule to place a drug in or if it should be rescheduled, there are eight factors the DEA must consider which are...

Recently the DEA reclassified hydrocodone from a CIII to a CII. In determining which schedule to place a drug in or if it should be rescheduled, there are eight factors the DEA must consider which are listed inSection 201 (c), [21 U.S.C. § 811 © Controlled Substance Act.

Search for a source on the internet on hydrocodone use and abuse in the United States. After reading Section 201 (c) and looking at hydrocodone use in the US, do you think the DEA made the right decision and why? Do you see any reasons why this could have been a poor decision or negatively impact patients?